News

Professor George Follows and clinical colleagues at CUH
Making chemotherapy for Hodgkin lymphoma kinder to patients

New research has found a change to the chemotherapy regimen for people with Hodgkin lymphoma could reduce the long-term health impacts from treatment.Read more

Icon representing heart rate. From Flaticon.
NIHR Cambridge BRC-funded research is top-five most-cited in world-leading general cardiology publication

Research from the University of Cambridge’s Cardiovascular Epidemiology Unit and funded by NIHR Cambridge BRC are listed in the top five most-cited papers in the European Heart Journal over 2023.Read more

Cytosponge
Landmark ‘Pill-On-A-Thread’ cancer screening trial welcomes first participants

A clinical trial of a “pill-on-a-thread” test, which will decide if it becomes a new screening programme for oesophageal cancer, has welcomed its first participant.Read more

Professor David Rowitch
NIHR Cambridge theme lead elected to National Academy of Medicine

Professor David Rowitch, NIHR Cambridge Antenatal, Maternal and Child Health theme lead, has been elected to the National Academy of Medicine.Read more

Meeting at NIHR Cambridge Clinical Research Facility (CRF) - NIHR Cambridge BRC image
NMAPs Pre-application for support funding now open

Nurses, midwives and allied health professionals (NMAPs) who want to join an NIHR career development scheme are being offered the chance to apply for a pre-application support fund.Read more

Nurses with clinical equipment - Image from Cambridge University Health Partners
MPhil in Translating Devices and Advanced Therapies Research

An exciting MPhil opportunity is available in our Devices and Advance Therapies theme to help develop your skills and knowledge. The MPhil will begin in 2025, applications close on 3 December 2024.Read more

Scientist looking down a microscope in the lab - NIHR Cambridge BRC image
Cambridge researchers awarded funding to establish Advanced Therapy Hub for the East of England

Researchers at Cambridge University Hospitals (CUH) have been awarded almost £1.5 million from the National Institute for Health and Care Research (NIHR) to purchase specialist equipment required to research, test and deliver advanced Read more

Left Nicolas-Wisniacki and David-Thomas, right
Cambridge and GSK announce new five-year collaboration to help patients with hard-to-treat kidney and respiratory diseases 

GSK plc is making a five-year investment to establish the Cambridge-GSK Translational Immunology Collaboration (CG-TIC), with the University of Cambridge and Cambridge University Hospitals. The collaboration is focused on understanding the onset of Read more

Air con unit on the wards at CUH
New evidence about whether Air Cleaning Units reduce hospital-acquired infections

Cambridge researchers have been looking at whether Air Cleaning Units in hospital wards reduce hospital-acquired infections, particularly COVID-19.Read more

Patient and WBIC scanner - NIHR Cambridge BRC image
Ultra-powered MRI scans show damage to brain’s ‘control centre’ is behind long-lasting Covid-19 symptoms

Study suggests the brain’s ‘control centre’ is behind long-lasting physical and psychiatric effects of severe Covid-19 infectionRead more

Credit: Karen Arnott/EMBL-EBI
Polygenic Score Catalog increases diversity and usability of genetic data

A paper highlighting changes to the Polygenic Score (PGS) Catalog for genetic disease risk predictions for individuals of diverse genetic backgrounds has been published in leading journal Nature Genetics.
In the work, which Read more

An exploded view of the thin and flexible sensors and the “intelligent” trial liner for the breakthrough technology in hip replacement being developed at Cambridge
Team’s hip replacement surgery invention is set to be world first

Technology which is the first of its kind in the world and could transform the future of hip replacement surgery is being pioneered by a team of experts in Cambridge.Read more

IVORY trial team
Global spotlight on Cambridge heart trial

A Cambridge trial which may help prevent patients from having repeat heart attacks, will be presented at the 30th European Society of Cardiology (ESC) Congress, the largest cardiology conference globally.Read more

Prof Miles Parkes
The role of a SAB and why it’s important

A personal reflection of the Scientific Advisory Board from Professor Miles Parkes, Director of NIHR Cambridge BRC, with a short video from the SAB event from researchers giving their thoughts about why the NIHR Cambridge BRC is a special place to conduct research.Read more

PPI Showcase talk
Patient and Public Involvement week returns and is a huge hit

Nearly 200 people attended an exciting week of Patient and Public Involvement events, the first event of its kind held on the Cambridge Biomedical Campus.Read more

PPI showcase winners, Claire, Amy and Claire
Winners announced for 2024’s Cambridge PPI showcase event

Improving women’s access to pelvic health services, using drama and theatre to help interpret genetic data research and public engagement with paediatric IBD were all winners at the 2024 Cambridge Patient and Public Involvement (PPI) showcase.Read more

Graphic showing intelligence and data: Image by Gerd Altmann from Pixabay.
Artificial intelligence outperforms clinical tests at predicting progress of Alzheimer’s disease

Cambridge researchers have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain stable or develop Alzheimer’s disease.Read more

Nita Forouhi
Researcher awarded prestigious Academy of Medical Sciences Fellowship

Congratulations to Professor Nita Forouhi, NIHR Senior Investigator and co-theme lead for Nutrition, Obesity, Metabolism and Endocrinology, who has been elected as a fellow of the Academy of Medical Sciences.Read more

Fellows of the Royal Society 2024
Cambridge researchers elected as Fellows of the Royal Society 2024

Congratulations to our NIHR Cambridge BRC researchers who have been elected as Fellows of the Royal Society, the UK’s national academy of sciences.Read more

Opal Sandy gene therapy trial
Baby born deaf can hear after breakthrough gene therapy

A baby girl born deaf can hear unaided for the first time, after receiving ground-breaking gene therapy trial supported by the NIHR Cambridge BRC. Read more

Discover more about the NIHR Cambridge BRC

Contact us by phone, email or web for more information.

Events Calendar

Listing relevant events and training sessions for researchers and members of the public.